Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2915)
All Articles published online
|
Nov 28, 2007 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang YD, Mao JW. Expression of matrix metalloproteinase-1 and tumor necrosis factor-α in ulcerative colitis. World J Gastroenterol 2007; 13(44): 5926-5932 [PMID: 17990358 DOI: 10.3748/wjg.v13.i44.5926] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5926.htm |
| Number | Citing Articles |
| 1 |
Satiesh Kumar Ramadass, Sathiamurthi Perumal, Sugin Lal Jabaris, Balaraman Madhan. Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis. European Journal of Pharmaceutical Sciences 2013; 48(1-2): 104 doi: 10.1016/j.ejps.2012.10.015
|
| 2 |
Daniel S. Pearl, Krina Shah, Mark A. Whittaker, Harriet Nitch-Smith, James F. Brown, Janis K. Shute, Timothy M. Trebble. Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity. Journal of Crohn's and Colitis 2013; 7(6): 481 doi: 10.1016/j.crohns.2012.07.022
|
| 3 |
Satiesh Kumar Ramadass, Sugin Lal Jabaris, Ramesh Kannan Perumal, Villianur Ibrahim HairulIslam, Arun Gopinath, Balaraman Madhan. Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: A new treatment strategy. European Journal of Pharmaceutical Sciences 2016; 91: 216 doi: 10.1016/j.ejps.2016.05.015
|
| 4 |
Roosmarijn E. Vandenbroucke, Claude Libert. Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nature Reviews Drug Discovery 2014; 13(12): 904 doi: 10.1038/nrd4390
|
| 5 |
Ruth Rattigan, John V. O’Doherty, Stafford Vigors, Marion T. Ryan, Rocco S. Sebastiano, John J. Callanan, Kevin Thornton, Gaurav Rajauria, Lekha M. Margassery, Alan D. W. Dobson, Niall D. O’Leary, Torres Sweeney. The Effects of the Marine-Derived Polysaccharides Laminarin and Chitosan on Aspects of Colonic Health in Pigs Challenged with Dextran Sodium Sulphate. Marine Drugs 2020; 18(5): 262 doi: 10.3390/md18050262
|
| 6 |
Jessica Bauer, Gerhard Liebisch, Claudia Hofmann, Christian Huy, Gerd Schmitz, Florian Obermeier, Jürgen Bock, Stefan Bereswill. Lipid Alterations in Experimental Murine Colitis: Role of Ceramide and Imipramine for Matrix Metalloproteinase-1 Expression. PLoS ONE 2009; 4(9): e7197 doi: 10.1371/journal.pone.0007197
|
| 7 |
K. Sri Manjari, Pratibha Nallari, A. Vidyasagar, A. Jyothy, A. Venkateshwari. Plasma TGF-β1, MMP-1 and MMP-3 Levels in Chronic Pancreatitis. Indian Journal of Clinical Biochemistry 2012; 27(2): 152 doi: 10.1007/s12291-011-0167-6
|
| 8 |
Akinori Tokito, Michihisa Jougasaki. Matrix Metalloproteinases in Non-Neoplastic Disorders. International Journal of Molecular Sciences 2016; 17(7): 1178 doi: 10.3390/ijms17071178
|
| 9 |
Y. Yilmaz, O. Yonal, F. Eren, O. Atug, H. Over Hamzaoglu. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. Journal of Crohn's and Colitis 2011; 5(5): 402 doi: 10.1016/j.crohns.2011.03.011
|
| 10 |
William J. Sandborn, Atsushi Sakuraba, Anthony Wang, Dendy Macaulay, William Reichmann, Song Wang, Jingdong Chao, Martha Skup. Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States. Current Medical Research and Opinion 2016; 32(7): 1233 doi: 10.1185/03007995.2016.1168290
|
| 11 |
Christoffer Soendergaard, Ole Haagen Nielsen, Jakob Benedict Seidelin, Peter Helding Kvist, Jacob Tveiten Bjerrum. Alpha-1 Antitrypsin and Granulocyte Colony-stimulating Factor as Serum Biomarkers of Disease Severity in Ulcerative Colitis. Inflammatory Bowel Diseases 2015; 21(5): 1077 doi: 10.1097/MIB.0000000000000348
|
| 12 |
Deenaz Zaidi, Eytan Wine. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00317
|
| 13 |
Sen-Yuan Hong, Hong-Cheng Jiang, Wen-Chao Xu, He-Song Zeng, Shao-Gang Wang, Bao-Long Qin. Bioinformatics analysis reveals the potential role of matrix metalloproteinases in immunity and urolithiasis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1158379
|
| 14 |
Luiz G.N. de Almeida, Hayley Thode, Yekta Eslambolchi, Sameeksha Chopra, Daniel Young, Sean Gill, Laurent Devel, Antoine Dufour, Gunnar Schulte. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacological Reviews 2022; 74(3): 714 doi: 10.1124/pharmrev.121.000349
|
| 15 |
G Pedersen, T Saermark, T Kirkegaard, J Brynskov. Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium. Clinical and Experimental Immunology 2009; 155(2): 257 doi: 10.1111/j.1365-2249.2008.03836.x
|
| 16 |
Muhammad A. Saeed, Garrett Z. Ng, Jan Däbritz, Josef Wagner, Louise Judd, Jia-Xi Han, Poshmaal Dhar, Carl D. Kirkwood, Philip Sutton. Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity. Inflammatory Bowel Diseases 2017; 23(4): 593 doi: 10.1097/MIB.0000000000001045
|
| 17 |
Keisuke Jimbo, Yoshikazu Ohtsuka, Yuko Kojima, Kenji Hosoi, Naho Ohbayashi, Tamaki Ikuse, Yo Aoyagi, Tohru Fujii, Takahiro Kudo, Toshiaki Shimizu. Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients. Pediatrics International 2014; 56(6): 873 doi: 10.1111/ped.12362
|
| 18 |
Saritha Tantravedi, Farhad Vesuna, Paul T. Winnard, Marise R. Heerma Van Voss, Paul J. Van Diest, Venu Raman. Role of DDX3 in the pathogenesis of inflammatory bowel disease. Oncotarget 2017; 8(70): 115280 doi: 10.18632/oncotarget.23323
|
| 19 |
Magali de Bruyn, Jennifer Vandooren, Estefania Ugarte-Berzal, Ingrid Arijs, Séverine Vermeire, Ghislain Opdenakker. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016; 51(5): 295 doi: 10.1080/10409238.2016.1199535
|
| 20 |
Laura Mäkitalo, Kaija-Leena Kolho, Riitta Karikoski, Hannele Anthoni, Ulpu Saarialho-Kere. Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2010; 45(7-8): 862 doi: 10.3109/00365520903583863
|
| 21 |
JING-WEI MAO, HAI-YING TANG, XIAO-YAN TAN, YING-DE WANG. Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-α in a rat model of ulcerative colitis. Molecular Medicine Reports 2012; 6(5): 996 doi: 10.3892/mmr.2012.1021
|
| 22 |
Jun-Jie Hou, Liang Ding, Tao Yang, Yan-Fei Yang, Yue-Ping Jin, Xiao-Ping Zhang, A-Huo Ma, Yue-Hua Qin. The proteolytic activity in inflammatory bowel disease: insight from gut microbiota. Microbial Pathogenesis 2024; 188: 106560 doi: 10.1016/j.micpath.2024.106560
|
| 23 |
Alicja Derkacz, Paweł Olczyk, Krystyna Olczyk, Katarzyna Komosinska-Vassev. The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2021; 10(5): 1122 doi: 10.3390/jcm10051122
|
| 24 |
Shane O’Sullivan, John F. Gilmer, Carlos Medina. Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update. Mediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/964131
|
| 25 |
Giulia Pontarollo, Amrit Mann, Inês Brandão, Frano Malinarich, Marie Schöpf, Christoph Reinhardt. Protease‐activated receptor signaling in intestinal permeability regulation. The FEBS Journal 2020; 287(4): 645 doi: 10.1111/febs.15055
|
| 26 |
Tarek Kamal Motawi, Sherine Maher Rizk, Ahmed Hassan Shehata. Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease. Journal of Physiology and Biochemistry 2012; 68(4): 529 doi: 10.1007/s13105-012-0168-9
|
| 27 |
Vincent Mariaule, Aicha Kriaa, Souha Soussou, Soufien Rhimi, Houda Boudaya, Juan Hernandez, Emmanuelle Maguin, Adam Lesner, Moez Rhimi. Digestive Inflammation: Role of Proteolytic Dysregulation. International Journal of Molecular Sciences 2021; 22(6): 2817 doi: 10.3390/ijms22062817
|